FDA Classifies Muscular Dystrophy Newborn Screening Test into Class II with Special Controls

Summary

The FDA has classified the muscular dystrophy newborn screening test into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.